-
November 1, 2019 Lupin receives sANDA approval from US FDA for Levothyroxine Sodium Tablets USP AB rating to Reference Listed Drug, LEVOXYL®
-
October 23, 2019 Notice of Q2 FY2020 Board Meeting
-
October 22, 2019 Lupin receives U.S. FDA approval for Divalproex Sodium ER Tablets USP
-
October 18, 2019 Lupin’s Nagpur facility receives EIR from the U.S. FDA
-
October 9, 2019 Japan’s PMDA issues GMP Certificate to Lupin’s Unit II Mandideep facility
-
October 4, 2019 Lupin launches Mycophenolate Mofetil Capsules USP
-
October 3, 2019 Lupin Appoints Johnny Mikell as Global Head of Quality
-
October 1, 2019 Lupin Foundation trains 7000 plus farmers at the Natural Farming Workshop in Bharatpur
-
October 1, 2019 Lupin receives U.S. FDA approval for Extended Phenytoin Sodium Capsules USP
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications